The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Somersan, S.
Right arrow Articles by Bhardwaj, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Somersan, S.
Right arrow Articles by Bhardwaj, N.
The Journal of Immunology, 2001, 167: 4844-4852.
Copyright © 2001 by The American Association of Immunologists

Primary Tumor Tissue Lysates Are Enriched in Heat Shock Proteins and Induce the Maturation of Human Dendritic Cells1

Selin Somersan*, Marie Larsson*, Jean Francois Fonteneau*, Sreyashi Basu{dagger}, Pramod Srivastava{dagger} and Nina Bhardwaj2,*

* Rockefeller University, New York, NY 10021; and {dagger} University of Connecticut Medical School, Farmington, CT 06030

Upon exposure to lysates or supernatants of necrotic transformed cell lines, human dendritic cells (DCs) undergo maturation. In contrast, DCs exposed to apoptotic transformed cell lines or necrotic lysates of primary cells remain immature. Analysis of supernatants of necrotic transformed cell lines showed them to be enriched in the heat shock proteins (hsp)70 and gp96, in contrast to supernatants of primary cells. Likewise, cells from a variety of primary human tumors contained considerably higher levels of hsp than their normal autologous tissue counterparts. Of the majority of human tumors enriched in hsps (hsp70 and/or gp96), their corresponding lysates matured DCs. The maturation effect of tumor cell lysates was abrogated by treatment with boiling, proteinase K, and geldanamycin, an inhibitor of hsps, suggesting that hsps rather than endotoxin or DNA were the responsible factors. Supporting this idea, highly purified, endotoxin-depleted hsp70, induced DC maturation similar to that seen with standard maturation stimuli LPS and monocyte conditioned medium. These results suggest that the maturation activity inherent within tumor cells and lines is mediated at least in part by hsps. The release of hsps in vivo as a result of cell injury should promote immunity through the maturation of resident DCs.




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
M.-F. Tsan and B. Gao
Heat shock proteins and immune system
J. Leukoc. Biol., June 1, 2009; 85(6): 905 - 910.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
B. Valentinis, A. Capobianco, F. Esposito, A. Bianchi, P. Rovere-Querini, A. A. Manfredi, and C. Traversari
Human recombinant heat shock protein 70 affects the maturation pathways of dendritic cells in vitro and has an in vivo adjuvant activity
J. Leukoc. Biol., July 1, 2008; 84(1): 199 - 206.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. Lehnardt, E. Schott, T. Trimbuch, D. Laubisch, C. Krueger, G. Wulczyn, R. Nitsch, and J. R. Weber
A Vicious Cycle Involving Release of Heat Shock Protein 60 from Injured Cells and Activation of Toll-Like Receptor 4 Mediates Neurodegeneration in the CNS
J. Neurosci., March 5, 2008; 28(10): 2320 - 2331.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
N. Cools, P. Ponsaerts, V. F. I. Van Tendeloo, and Z. N. Berneman
Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells
J. Leukoc. Biol., December 1, 2007; 82(6): 1365 - 1374.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
U. Johansson, L. Walther-Jallow, A. Smed-Sorensen, and A.-L. Spetz
Triggering of Dendritic Cell Responses after Exposure to Activated, but Not Resting, Apoptotic PBMCs
J. Immunol., August 1, 2007; 179(3): 1711 - 1720.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Kurotaki, Y. Tamura, G. Ueda, J. Oura, G. Kutomi, Y. Hirohashi, H. Sahara, T. Torigoe, H. Hiratsuka, H. Sunakawa, et al.
Efficient Cross-Presentation by Heat Shock Protein 90-Peptide Complex-Loaded Dendritic Cells via an Endosomal Pathway
J. Immunol., August 1, 2007; 179(3): 1803 - 1813.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
U. Koedel, U. M. Merbt, C. Schmidt, B. Angele, B. Popp, H. Wagner, H.-W. Pfister, and C. J. Kirschning
Acute Brain Injury Triggers MyD88-Dependent, TLR2/4-Independent Inflammatory Responses
Am. J. Pathol., July 1, 2007; 171(1): 200 - 213.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Liu, Y. Yang, J. Dai, R. Medzhitov, M. A. Freudenberg, P. L. Zhang, and Z. Li
TLR4 Up-Regulation at Protein or Gene Level Is Pathogenic for Lupus-Like Autoimmune Disease
J. Immunol., November 15, 2006; 177(10): 6880 - 6888.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. H.M.G.M. den Brok, R. P.M. Sutmuller, S. Nierkens, E. J. Bennink, L. W.J. Toonen, C. G. Figdor, T. J.M. Ruers, and G. J. Adema
Synergy between In situ Cryoablation and TLR9 Stimulation Results in a Highly Effective In vivo Dendritic Cell Vaccine.
Cancer Res., July 15, 2006; 66(14): 7285 - 7292.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Shi, T. Cao, J. E. Connolly, L. Monnet, L. Bennett, S. Chapel, C. Bagnis, P. Mannoni, J. Davoust, A. K. Palucka, et al.
Hyperthermia Enhances CTL Cross-Priming
J. Immunol., February 15, 2006; 176(4): 2134 - 2141.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
W.-X. Zong and C. B. Thompson
Necrotic death as a cell fate.
Genes & Dev., January 1, 2006; 20(1): 1 - 15.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. J. Prasad, K. J. Farrand, S. A. Matthews, J. H. Chang, R. S. McHugh, and F. Ronchese
Dendritic Cells Loaded with Stressed Tumor Cells Elicit Long-Lasting Protective Tumor Immunity in Mice Depleted of CD4+CD25+ Regulatory T Cells
J. Immunol., January 1, 2005; 174(1): 90 - 98.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W. Ren, R. Strube, X. Zhang, S.-Y. Chen, and X. F. Huang
Potent Tumor-Specific Immunity Induced by an In vivo Heat Shock Protein-Suicide Gene-Based Tumor Vaccine
Cancer Res., September 15, 2004; 64(18): 6645 - 6651.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. SenGupta, P. J. Norris, T. J. Suscovich, M. Hassan-Zahraee, H. F. Moffett, A. Trocha, R. Draenert, P. J. R. Goulder, R. J. Binder, D. L. Levey, et al.
Heat Shock Protein-Mediated Cross-Presentation of Exogenous HIV Antigen on HLA Class I and Class II
J. Immunol., August 1, 2004; 173(3): 1987 - 1993.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. C. Bartholomae, F. H. Rininsland, J. C. Eisenberg, B. O. Boehm, P. V. Lehmann, and M. Tary-Lehmann
T Cell Immunity Induced by Live, Necrotic, and Apoptotic Tumor Cells
J. Immunol., July 15, 2004; 173(2): 1012 - 1022.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. D. H. Doody, J. T. Kovalchin, M. A. Mihalyo, A. T. Hagymasi, C. G. Drake, and A. J. Adler
Glycoprotein 96 Can Chaperone Both MHC Class I- and Class II-Restricted Epitopes for In Vivo Presentation, but Selectively Primes CD8+ T Cell Effector Function
J. Immunol., May 15, 2004; 172(10): 6087 - 6092.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M.-F. Tsan and B. Gao
Cytokine function of heat shock proteins
Am J Physiol Cell Physiol, April 1, 2004; 286(4): C739 - C744.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
J. Stebbing, P. Savage, S. Patterson, and B. Gazzard
All for CD91 and CD91 for all
J. Antimicrob. Chemother., January 1, 2004; 53(1): 1 - 3.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X. F. Huang, W. Ren, L. Rollins, P. Pittman, M. Shah, L. Shen, Q. Gu, R. Strube, F. Hu, and S.-Y. Chen
A Broadly Applicable, Personalized Heat Shock Protein-Mediated Oncolytic Tumor Vaccine
Cancer Res., November 1, 2003; 63(21): 7321 - 7329.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Stebbing, B. Gazzard, S. Portsmouth, F. Gotch, L. Kim, M. Bower, S. Mandalia, R. Binder, P. Srivastava, and S. Patterson
Disease-associated dendritic cells respond to disease-specific antigens through the common heat shock protein receptor
Blood, September 1, 2003; 102(5): 1806 - 1814.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. N. Rad, G. Pollara, S. M. A. Sohaib, C. Chiang, B. M. Chain, and D. R. Katz
The Differential Influence of Allogeneic Tumor Cell Death via DNA Damage on Dendritic Cell Maturation and Antigen Presentation
Cancer Res., August 15, 2003; 63(16): 5143 - 5150.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. A. Pilon, C. Kelly, and W.-Z. Wei
Broadening of Epitope Recognition During Immune Rejection of ErbB-2-Positive Tumor Prevents Growth of ErbB-2-Negative Tumor
J. Immunol., February 1, 2003; 170(3): 1202 - 1208.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Feng, Y. Zeng, M. W. Graner, A. Likhacheva, and E. Katsanis
Exogenous stress proteins enhance the immunogenicity of apoptotic tumor cells and stimulate antitumor immunity
Blood, January 1, 2003; 101(1): 245 - 252.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Bethke, F. Staib, M. Distler, U. Schmitt, H. Jonuleit, A. H. Enk, P. R. Galle, and M. Heike
Different Efficiency of Heat Shock Proteins (HSP) to Activate Human Monocytes and Dendritic Cells: Superiority of HSP60
J. Immunol., December 1, 2002; 169(11): 6141 - 6148.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Feng, Y. Zeng, M. W. Graner, and E. Katsanis
Stressed apoptotic tumor cells stimulate dendritic cells and induce specific cytotoxic T cells
Blood, December 1, 2002; 100(12): 4108 - 4115.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Noessner, R. Gastpar, V. Milani, A. Brandl, P. J. S. Hutzler, M. C. Kuppner, M. Roos, E. Kremmer, A. Asea, S. K. Calderwood, et al.
Tumor-Derived Heat Shock Protein 70 Peptide Complexes Are Cross-Presented by Human Dendritic Cells
J. Immunol., November 15, 2002; 169(10): 5424 - 5432.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. A. E. Harmala, E. G. Ingulli, J. M. Curtsinger, M. M. Lucido, C. S. Schmidt, B. J. Weigel, B. R. Blazar, M. F. Mescher, and C. A. Pennell
The Adjuvant Effects of Mycobacterium tuberculosis Heat Shock Protein 70 Result from the Rapid and Prolonged Activation of Antigen-Specific CD8+ T Cells In Vivo
J. Immunol., November 15, 2002; 169(10): 5622 - 5629.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
B. Liu, A. M. DeFilippo, and Z. Li
Overcoming Immune Tolerance to Cancer by Heat Shock Protein Vaccines
Mol. Cancer Ther., October 1, 2002; 1(12): 1147 - 1151.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Q. Xu
Role of Heat Shock Proteins in Atherosclerosis
Arterioscler Thromb Vasc Biol, October 1, 2002; 22(10): 1547 - 1559.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
O. Schulz, D. J. Pennington, K. Hodivala-Dilke, M. Febbraio, and C. Reis e Sousa
CD36 or {alpha}v{beta}3 and {alpha}v{beta}5 Integrins Are Not Essential for MHC Class I Cross-Presentation of Cell-Associated Antigen by CD8{alpha}+ Murine Dendritic Cells
J. Immunol., June 15, 2002; 168(12): 6057 - 6065.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
T. Iyoda, S. Shimoyama, K. Liu, Y. Omatsu, Y. Akiyama, Y. Maeda, K. Takahara, R. M. Steinman, and K. Inaba
The CD8+ Dendritic Cell Subset Selectively Endocytoses Dying Cells in Culture and In Vivo
J. Exp. Med., May 20, 2002; 195(10): 1289 - 1302.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. M. Vabulas, P. Ahmad-Nejad, S. Ghose, C. J. Kirschning, R. D. Issels, and H. Wagner
HSP70 as Endogenous Stimulus of the Toll/Interleukin-1 Receptor Signal Pathway
J. Biol. Chem., April 19, 2002; 277(17): 15107 - 15112.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. E. Chang, B. G. Redman, J. R. Whitfield, B. J. Nickoloff, T. M. Braun, P. P. Lee, J. D. Geiger, and J. J. Mule
A Phase I Trial of Tumor Lysate-pulsed Dendritic Cells in the Treatment of Advanced Cancer
Clin. Cancer Res., April 1, 2002; 8(4): 1021 - 1032.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.